EDIT vs NVR · rev $32.3M vs P/E 15, rev $10.52B
Editas Medicine Inc (EDIT) versus NVR Inc (NVR) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
NVR Inc (NVR) is a residential construction company listed on NYSE.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported NVR revenue for 2024-12-31 was $10.52B. Net income was $1.68B. Revenue was up 10.6% from 2023-12-31 to 2024-12-31. NVR currently screens at market cap $16.94B and trailing P/E 15.3.
EDIT currently screens at market cap $375.2M. NVR currently screens at market cap $16.94B and trailing P/E 15.3.
Not investment advice. Open the EDIT and NVR stock pages for the full models.
Not investment advice.